[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

New In-Demand Reports on Pharmaceutical Industry

11 Mar 2021 • by Natalie Aster

LONDON – Market Publishers is pleased to announce that a lot of new research reports covering the pharmaceutical industry have been recently added to our database. These studies provide in-depth insights into the industry landscape, discuss major growth drivers and restraints, highlight prevailing and emerging trends, outline major growth opportunities and challenges, examine the competitive environment and offer profiles of the leading players, uncover important details and cutting-edge statistics, include valuable forecast, and offer other important information. Here are the most popular latest reports on the pharmaceutical industry available at MarketPublishers.com:

Osteoporosis Drugs Market

The global osteoporosis drugs market is slated to increase at a 6.83% CAGR over 2021-2026, spurred by the rising prevalence of osteoporosis in postmenopausal women, enhancing awareness among the public about osteoporosis care, growing investment in R&D activities for the development of advanced new drug classes and a wide range of pipeline drugs for approval in clinical trials. By the year 2026, the value of the world’s osteoporosis drugs market is predicted to cross USD 20.1 billion. The injectable segment is expected to witness the highest CAGR during the forecast period owing to the rising need for drugs that exhibit improved bioavailability rapid mode of action…

Psychedelic Drugs Market 

The global psychedelic drugs market has registered considerable growth during 2018-2020, however, remains at an early stage in its life cycle, with most companies currently developing their “go-to-market” strategy. The market players of psychedelics are currently involved in the clinical trials of several psychedelic drugs to address mental and/or behavioral health indications, which continue to present significant unmet needs. The key players in the psychedelic drugs market are COMPASS Pathways, Mind Medicine, Numinus Wellness, and Johnson & Johnson. The most common psychedelic substances currently available in the market include Ketamine, Psilocybin, Ibogaine, LSD, Dimethyltryptamine (DMT), or MDMA. The world’s market for psychedelic drugs is slated for tremendous growth in the next 5 years, fueled by the rising prevalence of depression and mental disorders worldwide, favourable regulatory reforms, ongoing advancements in R&D in the psychedelics field, changing perceptions, and the introduction of cost-effective drugs with little severe side effects. Yet, the market also faces some challenges, for instance, uncertainty around getting the FDA approval, an early stage in the lifecycle of the psychedelics industry, stigma associated with psychedelic drugs use, among others… 

Contrast Agents Market 

The global contrast agents market is predicted to grow at a high single-digit CAGR between 2020 and 2027 to exceed USD 7 billion by the end of the forecast period. Such factors as the increasing incidence and prevalence of chronic diseases, mounting demand for diagnostic and interventional radiology procedures, rapidly aging population, expansion of contrast agent indications, increasing availability of medical imaging in emerging markets, an upturn in research activities, and favorable reimbursement are poised to act as the major growth drivers of the global contrast agents market in the next 6 years. Among applications, the cardiovascular sector commanded the biggest share of the overall contrast agents market in 2020 and is set to increase at the highest CAGR through 2026. As for regional markets, North America is expected to stay in the lead accounting for the dominant share and exhibiting high growth rates in the years ahead… 

Active Pharmaceutical Ingredients (API) Market 

The world’s Active Pharmaceutical Ingredients (APIs) market is slated for robust growth at a high single-digit CAGR through 2027, encouraged by the rising adoption of biologics in disease management along with increasing regulatory approvals, the expanding scope of the HPAPI market, patent expiration of major drugs, rising trend of outsourcing, and growing geriatric population. By 2027, the value of the global API market is poised to exceed USD 364.16 billion. Based on synthesis, the synthetic API segment is predicted to hold the biggest market share and register the highest growth rates through 2027. During 2021-2027, North America is expected to grab the largest share of the overall API market, whilst the highest growth rates are anticipated in the APAC region…

Contraceptive Drugs Market

The global contraceptive drugs market crossed the value of USD 14.32 billion in the year 2019 and is expected to exceed USD 24.41 billion by the year 2027. The world’s contraceptive drugs market is projected to register growth at a 6.9% CAGR in the next 7 years, supported by the increasing concerns about family planning and the necessity to prevent unintended pregnancy. Furthermore, the increasing usage of contraception among young women backed by the increasing higher educational attainment rates promotes the growth of the contraceptive drugs market. Moreover, certain health problems associated with teenage pregnancies, enhancing awareness of modern contraception methods, and increasing usage of oral pills as a crucial technique to avert unplanned pregnancy are expected to propel the growth of the market in the years to come…

A full collection of Market Publishers’ research studies on the pharmaceutical industry is available in this catalogue

© MarketPublishers.com, 2020

Analytics & News

Weekly Digest